Categories AlphaGraphs, Analysis, Retail

Skechers earnings preview: Wall St expects 13% jump in Q4 revenue

Shoemaker Skechers (SKX) will report fourth-quarter earnings results after the regular trading hours on Thursday, February 7. The company is expected to report a 13% increase in revenues to $1.1 billion.

The top line is expected to be boosted by strong demand for its products outside the domestic markets, primarily in China and Europe. Skechers has inked numerous partnerships and JVs to effectively deliver its products to key global markets.

Photo by Raka Rachgo on Unsplash

The company’s digital platform has also been slowly picking up and is expected to lift overall sales. However, only a part of this sales hike would be transferred to the bottom line as higher taxes and currency headwinds weigh on the results.

While the company management has given Q4 EPS guidance in the range of $0.20–0.25, analysts on an average expect earnings to be 23 cents per share.

During the earnings conference call, look out for management comments on the firm’s cost management strategies, besides its plan of action to boost international growth. Investors would also be interested to know what the company plans to do with its domestic wholesale business, which has been showing signs of weakness.

During the last reported quarter, revenue from the wholesale business fell 3% year-over-year.

SKECHERS USA third quarter 2018 Earnings Infographic

SKX stock has a 12-month average price target of $27.67, which is at a modest 1.6% upside from the last close. Therefore, even strong fourth-quarter results might keep a stock rally under check.

In Q3

In the last reported quarter, earnings declined modestly, but to a lesser extent compared to analysts’ forecast. The stock gained about 7% during the extended trading hours as the market responded positively to the results and upbeat outlook.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference, and much more!

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top